In preclinical studies involving rodent models of diet-induced obesity, chronic treatment with MCHR1 antagonists resulted in reductions in body weight most commonly in the single or low-double digit percentages. Here, MCHR1 is linked to obesity due to melanocortin 4 receptor deficiency.